Home
User Guide
What's in a MalaCard Search Guide Our Sources
Analysis Tools
GeneCards GeneAnalytics GeneAlaCart PathCards VarElect
News and Views Disease Lists/Categories
About
About MalaCards Datasets Our Publications Weizmann Institute LifeMap Discovery® Terms of Use MalaCards Team
MCID: CHL039
MIFTS: 37

Choledocholithiasis

Categories: Gastrointestinal diseases, Liver diseases
Genes Tissues Related diseases Publications Pathways Drugs
Sources

Aliases & Classifications for Choledocholithiasis

About this section

MalaCards integrated aliases for Choledocholithiasis:

Name: Choledocholithiasis 12 54 44 15 17 70

Classifications:

MalaCards categories:
Anatomical: Gastrointestinal diseases Liver diseases
See all MalaCards categories (disease lists)


External Ids:

Disease Ontology 12 DOID:11755
MeSH 44 D042883
SNOMED-CT 67 197397004
UMLS 70 C0701818
Sources

Summaries for Choledocholithiasis

About this section
MalaCards based summary : Choledocholithiasis is related to cholelithiasis and cholecystitis. An important gene associated with Choledocholithiasis is GPT (Glutamic--Pyruvic Transaminase), and among its related pathways/superpathways is Selenium Micronutrient Network. The drugs Meperidine and Midazolam have been mentioned in the context of this disorder. Affiliated tissues include liver, kidney and pancreas.

Wikipedia : 73 Common bile duct stone, also known as choledocholithiasis, is the presence of gallstones in the common... more...

Sources

Related Diseases for Choledocholithiasis

About this section

Diseases related to Choledocholithiasis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 362)
# Related Disease Score Top Affiliating Genes
1 cholelithiasis 31.3 UGT1A1 GPT CRP CCK ALB ABCB4
2 cholecystitis 31.0 GPT F2 CCK ALB ABCB4
3 acute pancreatitis 30.8 GPT CRP CCK
4 peritonitis 30.8 F2 CRP ALB
5 cholecystolithiasis 30.8 GPT ERVMER34-1 CRP CEACAM5 CCK ABCB4
6 acute cholangitis 30.6 GPT F2 CRP CEACAM5 ALB
7 suppurative cholangitis 30.6 GPT CRP ABCB4
8 biliary dyskinesia 30.5 GPT CCK
9 ascending cholangitis 30.4 GPT F2 CRP ALB
10 cholangitis 30.3 GPT GGT1 F2 CRP CEACAM5 ALPP
11 extrahepatic cholestasis 30.3 GPT GGT1 ABCB4
12 bile duct cysts 30.3 GPT CEACAM5 ALB ABCB4
13 hepatic coma 30.2 GPT F2 ALB
14 afferent loop syndrome 30.2 GPT ALB
15 obstructive jaundice 30.2 SLC17A5 GPT GGT1 F2 CRP ALPP
16 drug-induced hepatitis 30.0 UGT1A1 GPT ALB
17 hepatic encephalopathy 30.0 SLC17A5 GPT F2 ALB
18 acute kidney failure 30.0 GPT F2 ALB
19 portal hypertension 29.9 GPT F2 ALB
20 gilbert syndrome 29.9 UGT1A1 GPT ALB
21 sclerosing cholangitis 29.9 GPT GGT1 F2 ALB ABCB4
22 thrombophlebitis 29.9 F2 CRP ALB
23 pulmonary embolism 29.8 F2 CRP ALB
24 hemoglobinopathy 29.8 UGT1A1 CRP ALB
25 sickle cell anemia 29.7 UGT1A1 GPT F2 CRP ALB
26 diverticulitis 29.7 CRP CEACAM5 ALB
27 bronchopneumonia 29.7 GUSB GPT CRP ALB
28 alcohol use disorder 29.7 SLC17A5 GPT GGT1 ALB
29 neutropenia 29.7 UGT1A1 GPT CRP ALB
30 ileus 29.7 F2 CRP CCK
31 hyperthyroidism 29.7 GPT CRP ALPP ALB
32 respiratory failure 29.6 GPT F2 CRP ALB
33 cholestasis 29.6 SLC17A5 GPT GGT1 F2 CCK ALPP
34 liver cirrhosis 29.6 SLC17A5 GPT GGT1 F2 CRP ALPP
35 intestinal obstruction 29.6 GPT CRP CEACAM5 ALB
36 autoimmune hepatitis 29.5 SLC17A5 GPT GGT1 F2 ALB
37 bilirubin metabolic disorder 29.5 UGT1A1 SLC17A5 GPT GGT1 F2 CRP
38 biliary tract disease 29.5 GPT F2 CRP CEACAM5 CCK ALB
39 klatskin's tumor 29.3 SPATA20 GPT F2 CEACAM5 ALB
40 cholangitis, primary sclerosing 29.2 GPT GGT1 F2 CRP ALB ABCB4
41 gallbladder disease 29.2 UGT1A1 GPT CRP CEACAM5 CCK ALB
42 liver disease 29.2 UGT1A1 SLC17A5 GPT GGT1 F2 ALPP
43 primary biliary cholangitis 29.0 SLC17A5 GPT GGT1 F2 ALPP ALB
44 bile duct disease 29.0 GPT F2 CRP CEACAM5 CCK ALB
45 gallbladder disease 1 10.7
46 dipetalonemiasis 10.4 GPT ALB
47 heterophyiasis 10.4 GPT ALB
48 hepatoportal sclerosis 10.4 GPT F2
49 non-a-e hepatitis 10.4 F2 ALB
50 antipyrine metabolism 10.4 F2 ALB

Graphical network of the top 20 diseases related to Choledocholithiasis:



Diseases related to Choledocholithiasis
Sources

Symptoms & Phenotypes for Choledocholithiasis

About this section
Sources

Drugs & Therapeutics for Choledocholithiasis

About this section

Drugs for Choledocholithiasis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 40)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Meperidine Approved Phase 4 57-42-1 4058
2
Midazolam Approved, Illicit Phase 4 59467-70-8 4192
3
Ursodeoxycholic acid Approved, Investigational Phase 4 128-13-2 31401
4
Etomidate Approved Phase 4 33125-97-2 36339 667484
5 Anesthetics Phase 4
6 Neurotransmitter Agents Phase 4
7 Psychotropic Drugs Phase 4
8 Hypnotics and Sedatives Phase 4
9 Narcotics Phase 4
10 Anesthetics, General Phase 4
11 Anesthetics, Intravenous Phase 4
12 GABA Modulators Phase 4
13 Anti-Anxiety Agents Phase 4
14 Analgesics, Opioid Phase 4
15 Analgesics Phase 4
16
Cefoxitin Approved 35607-66-0 441199
17
Cefotaxime Approved 63527-52-6 456256 5742673
18
Propofol Approved, Investigational, Vet_approved 2078-54-8 4943
19
Glucagon Approved 16941-32-5
20
Chlorhexidine Approved, Vet_approved 55-56-1 9552079 2713
21
Indomethacin Approved, Investigational 53-86-1 3715
22
Scopolamine Approved, Investigational 51-34-3, 6533-68-2 5184
23
Pancrelipase Approved, Investigational 53608-75-6
24
Metoclopramide Approved, Investigational 364-62-5 4168
25 Plasminogen Inactivators Early Phase 1
26 Tissue Plasminogen Activator Early Phase 1
27 Plasminogen Activator Inhibitor 1 Early Phase 1
28 Plasminogen Early Phase 1
29 Cephalosporins
30 Anti-Bacterial Agents
31 Antibiotics, Antitubercular
32 Glucagon-Like Peptide 1
33 Anti-Infective Agents
34 Anti-Infective Agents, Local
35 Chlorhexidine gluconate
36 Disinfectants
37
Bilirubin 635-65-4 5280352
38 Butylscopolammonium Bromide
39 pancreatin
40 Liver Extracts

Interventional clinical trials:

(show top 50) (show all 64)
# Name Status NCT ID Phase Drugs
1 Endoscopic Treatment of Difficult Bile Duct Stones: Use of Direct Visualization System ("Spyglass Direct Visualization System") Associated With Electrohydraulic Lithotripsy (EHL) X Hydrostatic Balloon Dilation of the Major Duodenal Papilla Unknown status NCT02703077 Phase 4
2 Comparative Study on the Efficacy of Danshu Capsule and Ursodeoxycholic Acid Capsule in Preventing Recurrence of Choledocholithiasis Completed NCT04484870 Phase 4 oral Danshu capsule
3 Etomidate With Meperidine vs Midazolam With Meperidine for Sedation During Endodscopic Retrograde Cholangiopancreatogram (ERCP) Completed NCT02027311 Phase 4 Etomidate;Midazolam;Meperidine
4 Role of Indocyanine Green in Visualizing Critical View of Safety During Laparoscopic Cholecystectomy for Acute Cholecystitis Not yet recruiting NCT04624841 Phase 4 Indocyanine Green
5 Endoscopic Sphincterotomy Plus Large-Balloon Dilatation (ESLBD) Versus Conventional Endoscopic Treatment for Removal of Large Common Bile Duct Stones : A Prospective Comparative Multi Center Randomized Study Completed NCT02592811 Phase 3
6 Prospective Randomized Clinical Study for Timing of Laparoscopic Cholecystectomy After Endoscopic Retrograde Cholangiography for Acute Biliary Pancreatitis Unknown status NCT01687959 Early Phase 1
7 Laparoendoscopic Rendez Vous (Intraoperative ERCP) vs Two Stage Approach (Preoperative ERCP Followed by Laparoscopic Cholecystectomy) for the Management of Cholelithiasis/Choledocholithiasis Unknown status NCT00416234
8 A Prospective Randomized Multicenter Study Comparing Different Dilation Durations During Endoscopic Papillary Balloon Dilatation for Bile Duct Stones. Unknown status NCT00451581
9 Comparison of Endoscopic Papillary Balloon Dilatation and Sphincterotomy for CBD Stones With Difficult Sphincterotomy or Distal CBD Tapering Unknown status NCT00329888
10 Effectiveness of Prophylactic Antibiotics to Prevent Post Endoscopic Retrograde Cholangio Pancreatography Bacteremia in Biliary Obstruction Patient Unknown status NCT02958059
11 Endoscopic Retrograde Cholangiopancreatography, Endoscopic Ultrasound and Interventional Endoscopy in Pancreatico-biliary, Gastrointestinal and Esophageal Disorders Unknown status NCT01438385
12 Prospective Study of Bacteremia and Infection Rates Following Cholangioscopy With the Spyglass Cholangioscope Unknown status NCT01414400
13 Optimization and Cost-effective Analysis of Secondary Biliary Stones' Managements - A Multicenter, Prospective and Retrospective Cohort Study Based on Case Register System Unknown status NCT02554097
14 Direct Peroral Cholangioscopy by Using an Ultra-slim Upper Endoscope Unknown status NCT02276157
15 Gastrointestinal Microbiomes in Patients of Recurrent Common Bile Duct Stones After Endoscopic Sphincterotomy（EST） Unknown status NCT03102281
16 Impact of Choledochotomy Techniques During Laparoscopic CBD Exploration on Short- and Long-term Clinical Outcomes: Time to Change Concepts Completed NCT04463381
17 Early Endoscopic Ultrasound (EUS) in Acute Biliary Pancreatitis: a Prospective Pilot Study Completed NCT02430285
18 Influence of the Endoscopist Case Volumen on Endoscopic Retrograde CholangioPanceratography Outcomes Completed NCT04705740
19 Endosonography Versus Magnetic Resonance Cholangiopancreatography for Choledocholithiasis for Intermediate Risk of Choledocholithiasis (as Per European Society of Gastrointestinal Endoscopy Guidelines )- Randomized Controlled Trial Completed NCT04173624
20 Prospective Randomized Trial of Laparoscopic Cholecystectomy Plus Laparoscopic Common Bile Duct Exploration (LC + LCBDE) Versus Endoscopic Retrograde Cholangiopancreatography Sphincterotomy Plus Laparoscopic Cholecystectomy (ERCP/S + LC) for Common Bile Duct Stone Disease Completed NCT00807729
21 Role of EUS in High Risk of Choledocholithiasis Completed NCT03250286
22 Effect of 8.5 F Plastic Stent Without Proximal Flap on Prevention of Post-ERCP Cholangitis on Patients With choledocholithiasis--a Prospective Randomized Trial Completed NCT02594891
23 "Single Setting ERCP and Laparoscopic Cholecystectomy is a Safe Procedure in Patients With Cholecysto-Choledocholithiasis: A Prospective Study in a Peripheral-Level Hospital" Completed NCT04213092
24 The Clinical Characteristics of the Patients With Choledocholithiasis Without Cholangitis Showing the High Level of Aminotransferase and the Establishment of New Nomenclature ; Gallstone Hepatitis Completed NCT02647593
25 Preoperative Versus Intraoperative Endoscopic Sphincterotomy for Management of Choledocholithiasis and Cholecystolithiasis Completed NCT01046552
26 Laparoscopy-Assisted Transgastric Endoscopic Retrograde Cholangiopancreatography for Choledocholithiasis After Roux-en-Y Gastric Bypass Completed NCT03925766
27 A Prospective, Randomized Study Comparing Efficacy and Safety Between Left Lateral Position and Prone Position for Endoscopic Retrograde Cholangiopancreatography Completed NCT02594475
28 Prospective Study of the Risk of Bacteremia in Directed Cholangioscopic Examination of the CBD Completed NCT01673269
29 A Prospective Randomized Trial Comparing EUS Guided ERCP Without Fluoroscopy With Standard ERCP in Common Bile Duct Stone Removal Completed NCT02870686
30 Prospective Multicenter Evaluation of a New Short-access-cholangioscope for Biliary Duct Strictures and Gall Stones Completed NCT01683240
31 Initial Cholecystectomy With Intraoperative Cholangiography for Patients at Intermediate Risk of Common Bile Duct Stone Migration : Prospective Validation and Analysis Completed NCT02461147
32 Early Versus Delayed Laparoscopic Cholecystectomy Following ERCP in Concomitant Gallstones and Common Bile Duct Stones Completed NCT04475796
33 Loop-tipped Guidewire in Selective Biliary Cannulation: a Prospective, Randomized, Controlled Trial Completed NCT02028845
34 Treatment of Choledocolithiasis by Laparoscopic Exploration of The Bile Tract After Failed Endoscopic Cholangiopancreatography Completed NCT04690101
35 Randomized Trial of Combination of Cholangioscopic Guided Laser Lithotripsy and Conventional Mechanical Versus Conventional Mechanical Methods for the Endoscopic Removal of Large Bile Duct Stones Completed NCT01759979
36 Study of Endoscopic Sphincterotomy With Needle Knife Papillotome in Patients of Ampullary Impacted Stone Completed NCT00173368
37 Long-term Risks After Endoscopic Retrograde Cholangiopancreatography (ERCP) With Sphincterotomy. Completed NCT04735224
38 Prospective Evaluation of the Ability of Spyglass Cholangioscopy to Facilitate Radiation Free ERCP Completed NCT03074201
39 The Laryngeal Mask Airway Supreme (TM) is an Effective Alternative to Laryngoscope-guided Tracheal Intubation for Patients Undergoing Elective Laparoscopic Cholecystectomy-- A Prospective Randomized Controlled Trial Completed NCT02037958
40 A Randomized Controlled Trial Comparing Post-operative Pain in Single-incision Laparoscopic Cholecystectomy Versus Conventional Laparoscopic Cholecystectomy Completed NCT01824186
41 Success of Routine Intraoperative Cholangiography Completed NCT04052633
42 Low-pressure vs Standard-pressure in Laparoscopic Cholecystectomy. A Randomized Controlled Trial Evaluating the Quality of Recovery Measured by QoR-40 Completed NCT04146090
43 Prospective Randomized Trial of Cholangioscopy Guided Intraductal Lithotripsy Versus Papillary Balloon Dilation for the Endoscopic Treatment of Large Bile Duct Stones Recruiting NCT03536247
44 CO2 Cholangiography as an Alternative to Iodinated Contrast in Endoscopic Retrograde Cholangiopancreatography Recruiting NCT02611453
45 Comparison of Two Management Strategies, "Endoscopy First" and "Laparoscopic Cholecystectomy First", for Patients With Gallbladder Stones and Intermediate Risk for Choledocholithiasis Recruiting NCT03658863
46 Division of Hepato-gastroenterology; Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung,Taiwan Recruiting NCT03754491
47 Symbolic Regression Model To Predict Choledocholithiasis: Prospective Validation Recruiting NCT04410848
48 EPBD+Small EST VS. Large EST in Patients With Choledocholithiasis Complicated With Duodenal Papillary Diverticula Recruiting NCT04254887
49 A Long Term Complications Comparison of Laparoscopic Common Bile Duct Exploration and Cholecystectomy Versus Sequential ERCP Followed by Laparoscopic Cholecystectomy for Choledocholithiasis: a Multicenter Randomized Controlled Study Recruiting NCT02515474
50 If Chronic Gallbladder Diseases Increase the Occurence of Post Endoscopic Retrograde Choledochopancreatography Choledocholithiasis（a Prospective Multi-center Cohort Study） Recruiting NCT04242394

Search NIH Clinical Center for Choledocholithiasis

Cochrane evidence based reviews: choledocholithiasis

Sources

Genetic Tests for Choledocholithiasis

About this section
Sources

Anatomical Context for Choledocholithiasis

About this section

MalaCards organs/tissues related to Choledocholithiasis:

40
Liver, Kidney, Pancreas, Heart, Colon, Bone Marrow, Spinal Cord
Sources

Publications for Choledocholithiasis

About this section

Articles related to Choledocholithiasis:

(show top 50) (show all 3998)
# Title Authors PMID Year
1
Role of liver function tests in predicting common bile duct stones in acute calculous cholecystitis. 54 61
16078299 2005
2
Marked elevation in serum transaminases: an atypical presentation of choledocholithiasis. 61 54
15667485 2005
3
[Usefulness of endoscopic cholangiography and sphincterotomy in patients with biliary lithiasis]. 54 61
15765973 2004
4
[Predictors of choledocholithiasis in patients sustaining gallstones]. 61 54
15286869 2004
5
Lipopolysaccharides and beta-glucuronidase activity in choledochal bile in relation to choledocholithiasis. 61 54
9383634 1997
6
Increased intercellular adhesion molecule-1 serum concentration in cholestasis. 54 61
9007716 1996
7
Predicting the presence of choledocholithiasis in patients with symptomatic cholelithiasis. 54 61
8677945 1996
8
Jaundice. 54 61
1543099 1992
9
Is subtotal cholecystectomy safe and feasible? Short- and long-term results. 61
33058478 2021
10
Acute cholecystitis in a patient with choledochal cyst and concomitant choledocholithiasis. 61
33650744 2021
11
Massive biliary ascariasis: an unusual cause of acute cholangitis. 61
33762275 2021
12
Safety, quality and efficiency of intra-operative imaging for treatment decisions in patients with suspected choledocholithiasis without pre-operative magnetic resonance cholangiopancreatography. 61
33661381 2021
13
One-stage versus two-stage management for acute cholecystitis associated with common bile duct stones: a retrospective cohort study. 61
33788028 2021
14
Role of laparoscopy in the treatment of internal biliary fistulas in a high-volume center and a review of the literature. 61
33791855 2021
15
A grey zone of hyperamylasemia following endoscopic retrograde cholangiopancreatography: follow-up and differential diagnosis from acute pancreatitis. 61
33786115 2021
16
Effect of stent placement on stone recurrence and post-procedural cholangitis after endoscopic removal of common bile duct stones. 61
32829571 2021
17
Laparoscopic common bile duct exploration with primary closure is beneficial for patients with previous upper abdominal surgery. 61
33650005 2021
18
Prognostic factors associated with six month mortality of critically ill elderly patients admitted to the intensive care unit with severe acute cholangitis. 61
32839088 2021
19
Routine postoperative blood tests fail to reliably predict procedure-related complications after laparoscopic cholecystectomy. 61
33760977 2021
20
[Elevated CA19-9 levels; not always cancer]. 61
33651490 2021
21
Laparoscopic common bile duct exploration for patients with a history of prior biliary surgery: a comparative study with an open approach. 61
33369850 2021
22
Outcomes of laparoscopic bile duct exploration for choledocholithiasis with small common bile duct. 61
33748229 2021
23
One-step percutaneous transhepatic cholangioscopic lithotripsy in patients with choledocholithiasis. 61
33744724 2021
24
The Role of Transaminases in Predicting Choledocholithiasis. A Novel Predictive Composite Score Development in a Cohort of 1089 Patients Undergoing Laparoscopic Cholecystectomy. 61
33710916 2021
25
Do the 2019 ASGE choledocholithiasis guidelines reduce diagnostic ERCP? 61
33712227 2021
26
Porcine Aorto-Renal Artery (PARA) model for laparoscopic transcystic common bile duct exploration: the evolution of a training model to meet new clinical needs. 61
33595704 2021
27
Percutaneous stone removal using a compliant balloon after papillary balloon dilatation. 61
33612051 2021
28
Safety and Efficacy of Percutaneous Gallstone Extraction in High-Risk Patients: An Alternative to Cholecystectomy or Long-Term Drainage? 61
33010429 2021
29
Quality of Life Outcomes Following Single-stage Laparoscopic Common Bile Duct Exploration Versus 2-stage Endoscopic Sphincterotomy Followed by Laparoscopic Cholecystectomy in Management of Cholelithiasis With Choledocholithiasis. 61
33538548 2021
30
Managing Gallstone Disease in the Elderly. 61
33213774 2021
31
Treatment of acute exacerbation of liver-cirrhosis-associated portal vein thrombosis with direct-acting oral anticoagulant, edoxaban, used as an initial treatment in the early postoperative period after abdominal surgery: a case report. 61
33563326 2021
32
One-step versus two-step procedure for management procedures for management of concurrent gallbladder and common bile duct stones. Outcomes and cost analysis. 61
33650990 2021
33
Idiopathic acute pancreatitis-A myth or reality? Role of endoscopic ultrasonography and magnetic resonance cholangiopancreatography in its diagnosis. 61
33548019 2021
34
SUCCESS OF SINGLE-BALLOON ENTEROSCOPE-ASSISTED ERCP IN PATIENTS WITH MODIFIED ANATOMY. 61
33618534 2021
35
Safety and efficacy of laparoscopic common bile duct exploration for the patients with difficult biliary stones: 8 years of experiences at a single institution and literature review. 61
33619595 2021
36
Laparoscopic-assisted ERCP following RYGB: a 12-year assessment of outcomes and learning curve at a high-volume pancreatobiliary center. 61
33543349 2021
37
Endoscopic Ultrasound Quality Metrics in Clinical Practice. 61
33557251 2021
38
Difficult biliary stones in the elderly: Endoscopic retrograde cholangiography - A single surgical tertiary centre experience with follow-up. 61
33605927 2021
39
Etiological diagnosis of linear-array endoscopic ultrasonography in distal common bile duct dilatation. 61
33560105 2021
40
Dilation assisted stone extraction for complex biliary lithiasis: Technical aspects and practical principles. 61
33623638 2021
41
Could cholecystectomy be abondoned after removal of bile duct stones by endoscopic retrograde cholangiopancreaticography? 61
33573924 2021
42
Multicenter experience with digital single-operator cholangioscopy in pregnant patients. 61
33532547 2021
43
Image-Guided Surgery for Common Bile Duct Stones After Roux-en-Y Gastric Bypass. 61
33306942 2021
44
Dormia basket impacted during ERCP, resolved by laparoscopic bile duct approach: Case report. 61
33434770 2021
45
Emergency open surgery with a duodenotomy and successful removal of an impacted basket following a complicated endoscopic retrograde cholangiopancreatography procedure: a case report. 61
33618756 2021
46
A prospective multicenter analysis from the Pediatric ERCP Database Initiative: predictors of choledocholithiasis at ERCP in pediatric patients. 61
33539907 2021
47
Best evidence topic: Should patients with asymptomatic choledocholithiasis be treated differently from those with symptomatic or complicated disease? 61
33520213 2021
48
3D laparoscopic common bile duct exploration versus 2D in choledocholithiasis patients: a propensity score analysis. 61
32198551 2021
49
Bile duct clearance and cholecystectomy for choledocholithiasis: Definitive single-stage laparoscopic cholecystectomy with intraoperative endoscopic retrograde cholangiopancreatography versus staged procedures. 61
33075026 2021
50
Long-term Outcomes of Therapeutic Endoscopic Retrograde Cholangiopancreatography for Choledocholithiasis in Patients ≥90 Years Old: A Multicenter Retrospective Study. 61
33551408 2021
Sources

Variations for Choledocholithiasis

About this section
Sources

Expression for Choledocholithiasis

About this section
Search GEO for disease gene expression data for Choledocholithiasis.
Sources

Pathways for Choledocholithiasis

About this section

Pathways related to Choledocholithiasis according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1
Selenium Micronutrient Network 1
Show member pathways
 11.26 GGT1 F2 CRP ALB
Sources

GO Terms for Choledocholithiasis

About this section

Cellular components related to Choledocholithiasis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 extracellular space GO:0005615 9.5 GUSB GPT GGT1 F2 CRP CCK
2 extracellular region GO:0005576 9.23 SPATA20 GUSB F2 ERVMER34-1 CRP CEACAM5

Biological processes related to Choledocholithiasis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 acute-phase response GO:0006953 8.8 UGT1A1 F2 CRP
Sources

Sources for Choledocholithiasis

About this section
3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
20 GARD
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
53 NINDS
54 Novoseek
56 OMIM via Orphanet
57 OMIM® (Updated 20-May-2021)
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 Tocris
70 UMLS
71 UMLS via Orphanet
The MalaCards human disease database index: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Content
Loading form....